OBSIDIO

Obsidio, Inc. is an early-stage medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels anywhere in the body regardless of the patient’s coagulopathy. The technology can be used to control bleeding, close off vessels supplying blood to tumor, eliminate abnormal connections between arteries and veins, and treat aneurysms.

#SimilarOrganizations #People #Financial #Website #More

OBSIDIO

Social Links:

Twitter

Industry:

Health Care Medical Device

Founded:

2018-12-01

Address:

Columbia, South Carolina, United States

Country:

United States

Website Url:

http://www.obsidiomed.com

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

4.77 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Tag Manager WordPress Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins Typekit

Similar Organizations

injectsense-logo

Injectsense

Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.

true-digital-surgery-logo

True Digital Surgery

True Digital Surgery builds a 3D digital surgery visualization platform that improves visualization for a wide range of surgical procedures.

Current Employees Featured

rahmi-oklu_image

Rahmi Oklu
Rahmi Oklu Founder and Chief Medical Officer @ Obsidio
Founder and Chief Medical Officer
2019-01-01

ali-khademhosseini_image

Ali Khademhosseini
Ali Khademhosseini Co-Founder @ Obsidio
Co-Founder

ehsan-jabbarzadeh_image

Ehsan Jabbarzadeh
Ehsan Jabbarzadeh Founder and CEO @ Obsidio
Founder and CEO
2019-01-01

Founder

ali-khademhosseini_image

Ali Khademhosseini

ehsan-jabbarzadeh_image

Ehsan Jabbarzadeh

rahmi-oklu_image

Rahmi Oklu

Investors List

iag-capital-partners_image

Official Site Inspections

http://www.obsidiomed.com Semrush global rank: 10.31 M Semrush visits lastest month: 9

Host Informations
Whois Informations

Loading ...